Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of Ustekinumab to NHS Wales.
Framework contract: £6,532,463 total value shared among 6 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| Amgen Ltd | Procurement ID: PDJG-8184-TCQQ | ~£1,088,744 | 1 lot Lot 1 | - |
| Celltrion Healthcare | Procurement ID: PYQL-4248-PXXY | ~£1,088,744 | 1 lot Lot 1 | - |
| Fresenius Kabi Ltd | Procurement ID: PZVH-4892-PJYY | ~£1,088,744 | 1 lot Lot 1 | - |
| Gedeon Richter | Procurement ID: PVNN-9371-ZTBW | ~£1,088,744 | 1 lot Lot 1 | - |
| Sandoz Ltd | Procurement ID: PNQL-1548-CYBZ | ~£1,088,744 | 1 lot Lot 1 | - |
| Thornton & Ross | Procurement ID: PWYH-6892-QYNN | ~£1,088,744 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 6 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Oct 2026 – Jun 2028 | £9,489,301 £6,532,463 initial term | 6 | Amgen Ltd Fresenius Kabi Ltd Celltrion Healthcare Gedeon Richter Sandoz Ltd Thornton & Ross | active |
Weightings from the notice.